CN105213639A - 脱发预防及修复调配物 - Google Patents
脱发预防及修复调配物 Download PDFInfo
- Publication number
- CN105213639A CN105213639A CN201510386004.2A CN201510386004A CN105213639A CN 105213639 A CN105213639 A CN 105213639A CN 201510386004 A CN201510386004 A CN 201510386004A CN 105213639 A CN105213639 A CN 105213639A
- Authority
- CN
- China
- Prior art keywords
- oil
- hair
- composite
- alopecia
- oleum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 63
- 201000004384 Alopecia Diseases 0.000 title claims abstract description 60
- 231100000360 alopecia Toxicity 0.000 title claims abstract description 58
- 230000002265 prevention Effects 0.000 title abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 27
- 230000001737 promoting effect Effects 0.000 claims abstract description 4
- 239000003921 oil Substances 0.000 claims description 111
- 235000019198 oils Nutrition 0.000 claims description 110
- 235000014593 oils and fats Nutrition 0.000 claims description 23
- 239000004006 olive oil Substances 0.000 claims description 19
- 235000008390 olive oil Nutrition 0.000 claims description 19
- TVQGDYNRXLTQAP-UHFFFAOYSA-N ethyl heptanoate Chemical compound CCCCCCC(=O)OCC TVQGDYNRXLTQAP-UHFFFAOYSA-N 0.000 claims description 17
- 239000008132 rose water Substances 0.000 claims description 17
- 239000010670 sage oil Substances 0.000 claims description 17
- 210000000582 semen Anatomy 0.000 claims description 17
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 claims description 16
- 241000208983 Arnica Species 0.000 claims description 16
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 15
- 229940119170 jojoba wax Drugs 0.000 claims description 15
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims description 15
- 239000010677 tea tree oil Substances 0.000 claims description 15
- 229940111630 tea tree oil Drugs 0.000 claims description 15
- 125000005456 glyceride group Chemical group 0.000 claims description 14
- 235000013311 vegetables Nutrition 0.000 claims description 14
- 244000042664 Matricaria chamomilla Species 0.000 claims description 13
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 13
- 235000013709 carrot oil Nutrition 0.000 claims description 13
- 239000010627 cedar oil Substances 0.000 claims description 12
- 238000011282 treatment Methods 0.000 claims description 12
- 239000003292 glue Substances 0.000 claims description 11
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 9
- 229920000223 polyglycerol Polymers 0.000 claims description 9
- 230000003646 hair health Effects 0.000 claims description 7
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 claims description 7
- 210000004209 hair Anatomy 0.000 abstract description 87
- 210000004761 scalp Anatomy 0.000 abstract description 63
- 230000003779 hair growth Effects 0.000 abstract description 24
- 230000003656 anti-hair-loss Effects 0.000 abstract description 12
- 210000004919 hair shaft Anatomy 0.000 abstract description 11
- 230000008569 process Effects 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 8
- 230000003660 hair regeneration Effects 0.000 abstract description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 5
- 239000011707 mineral Substances 0.000 abstract description 5
- 230000003700 hair damage Effects 0.000 abstract description 4
- 231100000419 toxicity Toxicity 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 210000003780 hair follicle Anatomy 0.000 description 23
- 210000003491 skin Anatomy 0.000 description 20
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 19
- 208000001840 Dandruff Diseases 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- 201000004624 Dermatitis Diseases 0.000 description 11
- 229930003427 Vitamin E Natural products 0.000 description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 10
- 235000019165 vitamin E Nutrition 0.000 description 10
- 239000011709 vitamin E Substances 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 229940046009 vitamin E Drugs 0.000 description 8
- 241001116389 Aloe Species 0.000 description 7
- 235000011399 aloe vera Nutrition 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 201000004681 Psoriasis Diseases 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000005802 health problem Effects 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- 206010044625 Trichorrhexis Diseases 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 230000000843 anti-fungal effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 3
- 206010049865 Achromotrichia acquired Diseases 0.000 description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 3
- -1 Jojoba oil Substances 0.000 description 3
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 3
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 3
- 244000025272 Persea americana Species 0.000 description 3
- 235000008673 Persea americana Nutrition 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 241001080929 Zeugopterus punctatus Species 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229960003473 androstanolone Drugs 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229940106189 ceramide Drugs 0.000 description 3
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 229960004039 finasteride Drugs 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 210000001732 sebaceous gland Anatomy 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 235000015170 shellfish Nutrition 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 241000220645 Leonotis nepetifolia Species 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 240000004713 Pisum sativum Species 0.000 description 2
- 235000010582 Pisum sativum Nutrition 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229920002770 condensed tannin Polymers 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- 239000002417 nutraceutical Substances 0.000 description 2
- 235000021436 nutraceutical agent Nutrition 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010062333 Congenital genital malformation Diseases 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 206010012435 Dermatitis and eczema Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 235000017011 Mandorlo dulce Nutrition 0.000 description 1
- 244000076313 Mandorlo dulce Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- XCOSWZFTYSIXED-UHFFFAOYSA-K P(=O)([O-])([O-])[O-].C(C)O[N+](C)(C)CCCCCCCCCCCCCCCC.C(C)O[N+](CCCCCCCCCCCCCCCC)(C)C.C(C)O[N+](CCCCCCCCCCCCCCCC)(C)C Chemical compound P(=O)([O-])([O-])[O-].C(C)O[N+](C)(C)CCCCCCCCCCCCCCCC.C(C)O[N+](CCCCCCCCCCCCCCCC)(C)C.C(C)O[N+](CCCCCCCCCCCCCCCC)(C)C XCOSWZFTYSIXED-UHFFFAOYSA-K 0.000 description 1
- 241000517307 Pediculus humanus Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 240000003946 Saponaria officinalis Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002086 anti-sebum Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000011928 denatured alcohol Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- SGZVXLFVBKDMJH-UHFFFAOYSA-M dihydrogen phosphate;hexadecyl-(2-hydroxyethyl)-dimethylazanium Chemical compound OP(O)([O-])=O.CCCCCCCCCCCCCCCC[N+](C)(C)CCO SGZVXLFVBKDMJH-UHFFFAOYSA-M 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003659 hair regrowth Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229940053957 hydroxyethyl cetyldimonium phosphate Drugs 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229950007687 macrogol ester Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 229940117382 propecia Drugs 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940107889 rogaine Drugs 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
具体化的本发明概言之是关于用于促进毛发生长、减缓脱发及用于预防脱发或使脱发减少至最小程度的组合物及其制造与使用方法,其能在一种产品中有效处理多方面问题,且由能大幅减少与现有产品相关的毒性及副作用问题的天然油及矿物质所构成。本发明的组合物或调配物是关于一种脱发解决方案,其借助处理多种与脱发相关联之原因及/或触发因素以从发根至头皮表面及毛干产生作用,或借助阻止毛发再生长,来解决与脱发及毛发损伤相关联的问题。
Description
技术领域
本发明是关于一种用于治疗脱发的调配物及其应用。
背景技术
市场上存在多种声称提供脱发解决方案的产品,然而该等产品通常仅处理一或二个方面的问题或仅全然的掩饰问题。脱发及毛发损伤存在多种原因。
脱发或秃头可由多种因素引起,包括遗传、激素缺乏或失衡、饮食、压力、疾病、化学治疗或老化。保持或恢复头发之期望导致历史上持续努力寻求用以刺激毛发生长及预防脱发或使脱发减少至最小程度的组合物及方法。
多年来,医药工业、营养食品工业及化妆品工业已试图研究及开发用以治愈或预防脱发或促进毛发生长的组合物。
存在手术及非手术解决方案用以解决脱发问题。用于治疗脱发的非手术选择包括各种促进毛发再生长及/或预防进一步脱发的各种医药品及营养食品的局部及/或口服治疗。举例而言,局部米诺地尔(topicalminoxidil),通常称为ROGAINE,涂覆于头皮时会引起毛发生长,且在一些个体中并刺激毛囊来减缓脱发速率。非那雄胺(Finasteride),通常称为PROPECIA,系一种经口服以借助阻断DHT形成来治疗雄性秃的药物。以医药品治疗脱发的问题在于该等药物的潜在副作用。米诺地尔可导致低血压、心率增加、因水滞留引起的重量增加,且头皮可能发炎。非那雄胺可导致男性婴儿生殖器畸形、阳痿、性欲降低、荨麻疹或皮疹及肿胀。
因此,尽管先前技术存在进步,但此项技术中仍需要用于促进毛发生长、减缓脱发及用于预防脱发或使脱发减少至最小程度的组合物,其可在一种产品中有效处理多方面问题,另外是由使得本发明产品的毒性及副作用问题大幅减少的天然油及矿物质所组成;且需要制造及使用此组合物的方法。
发明内容
本发明的实施态样概言的是关于脱发预防及修复产品,且更特定而言是关于借助在单一调配物中治疗多种与脱发相关联的病因来改良使用者在脱发及预防方面的效果的特定调配物。
其他实施态样包括用于促进毛发生长、减缓脱发且用于预防脱发或使脱发减少至最小程度的组合物,该等组合物能在一种产品中有效处理多方面脱发问题,另外是由使得本发明产品的毒性及副作用问题大幅减少的天然油及矿物质所构成;以及包括制造及使用此组合物的方法。
本发明的实施态样包含不同油与植物萃取物之调配物,其在调配一起时能够重建及复原毛囊及头皮以恢复毛发生长并预防进一步脱发。
本发明的一实施态样包括用于治疗脱发的调配物,包含:玫瑰水、案树油、蓖麻油、瑞香草油、迷迭香油、德国洋甘菊油、胡萝卜油、雪松木油(Cederwoodoil)、葡萄籽油、山金车油及伪胶原蛋白(Pseudocollagen)。其他实施态样亦可包括至少一种选自以下的油:椰子油、甜杏仁油、橄榄油、熏衣草油、荷荷芭油、茶树油及椰子油。其他实施态样又可包括至少一种选自以下的成分:植物甘油、牛油树油脂、鼠尾草油、安那根(Anagain)、贝夕波(Baicipil)及萨克胶耶欧夫拜欧(SucragelAOFBio)。
另一实施态样包括一种调配物,其包括以下每种成分的总体积百分比范围:25%至30%的玫瑰水、5%至10%的案树油、5%至8%的蓖麻油、5%至8%的瑞香草油、4%至6%的迷迭香油、3%至5%的德国洋甘菊油、3%至5%的胡萝卜油、2%至4%的椰子油、2%至4%的甜杏仁油、1%至3%的雪松木油、1%至3%的橄榄油、1%至3%的葡萄籽油、1%至3%的熏衣草油、0.5%至2.5%的山金车油、0.5%至2.5%的荷荷芭油、0.5%至2.0%的芦荟油、0.5%至2.0%的茶树油、0.5%至2.0%的伪胶原蛋白、0.5%至2.0%的植物甘油、0.5%至2.0%的牛油树油脂、0.1%至0.6%的鼠尾草油、8%至12%的聚甘油油酸酯、及2%至4%之PEG-7-甘油椰油酸酯。
另一实施态样包括一种调配物,其包括以下每种成分的总体积百分比范围:55%至65%的玫瑰水、2%至4%的案树油、2%至4%的蓖麻油、2%至4%的瑞香草油、1%至4%的迷迭香油、0.001%至1%的德国洋甘菊油、1%至3%的胡萝卜油、1%至3%的椰子油、1%至3%的甜杏仁油、0.5%至3%的雪松木油、0.01%至2%的橄榄油、0.01%至2%的葡萄籽油、0.01%至2%的熏衣草油、0.01%至2.5%的山金车油、0.01%至2.5%的荷荷芭油、0.01%至2.0%的茶树油、0.01%至2.0%的伪胶原蛋白、0.01%至2.0%的植物甘油、0.5%至2.0%的牛油树油脂、0.01%至1.0%的鼠尾草油、2%至6%的安那根、及2%至6%的贝夕波及5%至10%的萨克胶耶欧夫拜欧。
另一实施态样包括一种调配物,其包括以下每种成分之总体积百分比:28.8%的玫瑰水、7.4%的案树油、6.4%的蓖麻油、6.4%的瑞香草油、5.3%的迷迭香油、4.3%的德国洋甘菊油、4.3%的胡萝卜油、3.2%的椰子油、3.2%的甜杏仁油、2.1%的雪松木油、2.1%的橄榄油、2.1%的葡萄籽油、2.1%的熏衣草油、1.6%的山金车油、1.6%的荷荷芭油、1.1%的芦荟油、1.1%的茶树油、1.1%的伪胶原蛋白、1.1%的植物甘油、1.1%的牛油树油脂、0.3%的鼠尾草油、10.6%的聚甘油油酸酯及2.7%的PEG-7-甘油椰油酸酯。
又一实施态样包括一种调配物,其包括以下每种成分的总体积百分比:59.5%的玫瑰水、2.8%的案树油、2.4%的蓖麻油、2.4%的瑞香草油、2.0%的迷迭香油、0.1%的德国洋甘菊油、1.6%的胡萝卜油、1.2%的椰子油、1.2%的甜杏仁油、1.2%的雪松木油、0.8%的橄榄油、0.8%的葡萄籽油、0.8%的熏衣草油、0.6%的山金车油、0.6%的荷荷芭油、0.4%的茶树油、0.4%的伪胶原蛋白、0.4%的植物甘油、1.2%的牛油树油脂、0.1%的鼠尾草油、4%的安那根、4%的贝夕波、及7.5%的萨克胶耶欧夫拜欧。
其他方法包括使用如上文所述的具体化调配物以有助于预防、治疗及恢复毛发再生长及一般头皮与毛发健康的方法。
其他实施态样又包括用于调配如上文所述的调配物的方法。
附图说明
图1展示对毛干与头皮相关性的说明。
附图标记
1:毛干
3:毛囊
4:发根
5:毛球
6:皮脂腺。
具体实施方式
图1展示对与毛发及头皮相关联的解剖学元件的参考说明。本发明之实施例系关于一种脱发解决方案,其借助作用于发根4至头皮2表面且作用于毛干1来解决与脱发及毛发损伤相关联的问题。尽管许多产品声称作用于发根4至头皮2表面及毛干1,但该等产品通常仅处理引起潜在事件的一或二种原因或触发因素,或甚至更糟地其全然掩饰导致脱发的原因或触发因素。
如本文所用,术语“脱发”系指毛发自头皮脱落或毛发变稀。术语“预防脱发”是指预防及抑制脱发。又,术语“增强毛发生长”是指增强新发生长或现有毛发的健康生长。
毛发生长受各种因素影响,包括环境因素,诸如温度或日照、个体的营养状态及存在/不存在疾病、激素、分娩、暴露于辐射或各种药物等等。脱发的主要原因可大致分为内部生理因素及外部环境因素。内部生理因素例如包括5-α还原酶的活性增加,其借助将睾固酮(一种雄性激素)转化为二氢睾固酮(dihydrotestosterone;DHT)而增加皮脂分泌(自皮脂腺6)。外部环境因素例如包括由于血管收缩、头皮2干燥或其类似原因引起的血液循环不良所致的毛球5营养不良。因此,为预防脱发及增强毛发生长,必须借助扩张血管、向毛球5直接供应与毛发成分具备相同功能的物质、使用清洁剂或抗皮脂剂移除毛球5周围的多余皮脂或使用补湿剂预防头皮干燥来滋养毛球5。
由于如上文所述,脱发及毛发损伤存在多种触发因素及原因,因此本发明的实施态样经调配用以借助在单一调配物中解决广泛范围的脱发触发因素及原因,来处理个体的头皮2及毛发1原本存在的问题并使其减少至最低程度。具体化产品作用于头皮2及毛发1以使pH平衡至正常。此外,具体化调配物使毛发的过去、现状及未来稳定。在其第一个阶段,具体化调配物使毛囊3解除来自过去产品之所有杂质或内部杂质的毒性并阻止脱发。在其第二个阶段,具体化调配物借助滋养及强化毛囊3来为毛发1生长创造更佳的条件。在第三个阶段,调配物促使毛发再生长。且在其第四个阶段,调配物自毛发1之发根4至尖端滋养毛发。借助滋养毛囊3,毛干1得以额外受到滋养。最终效果是自内而外健康的美丽且外观健康的毛发。使用者注意到毛发的差异且毛发更具质感及光泽。具体化调配物中各成分组合一起作用以对经历脱发及/或变稀且通常毛发受损的使用者产生显著效果。
具体化调配物通常由全天然产品构成。具体化调配物由不同油与植物萃取物构成且经调配用以重建及复原毛囊以恢复毛发。具体化调配物有助于阻止脱发且借助恢复及滋养毛囊来复原毛发。
另外,具体化调配物可有助于因疾病、压力或环境及化学原因引起的脱发。具体化调配物借助渗透至毛囊中,且使毛囊解毒、滋养毛囊且将毛囊修复至更健康的形式来起作用。对毛囊的此解毒、滋养及修复在使用者单次使用后即显而易见,其中毛发显得更健康、更有光泽且更丰满并具有动感。随时间经过,使用者将注意到毛发变得更丰满且更厚重。与先前技术中的多种产品不同,具体化调配物处理问题的根本,而非仅借助处理引起脱发的不健康毛发的症状来掩饰缺点。
为使用具体化调配物达成最佳效果,使用者首先充分洗涤其毛发及头皮。将毛发用毛巾擦干且借助将调配物按摩至头皮上而将调配物涂覆至毛发及头皮上。随后使调配物保留在头皮上及毛发中历时20至30分钟,之后将其冲洗掉。在用于修复毛发及预防脱发的优化方法中,如上所述每周涂覆具体化调配物约4次历时第一个月,且随后逐渐减少至每周2次。此方法开始时的更集中努力有助于启动毛囊恢复。
对具体化调配物进行的研究表明在涂覆3至4次具体化调配物后脱发显著减少。另外,在使用1至3个月之后,毛发明显开始再生长。
对存在与毛发及头皮相关联的不同问题的人群进行研究。一些研究参与者由于压力及/或药物而大量脱发,其他则源于甲状腺或其他健康相关问题。
因压力、环境及药物引起脱发的人群具有较快的效果。然而,因甲状腺及其他健康问题引起脱发的人群仍显示阳性结果,但在可观察到改良迹象之前通常仍有必要进行更多治疗。
因继发性健康问题引起之脱发在改良头皮与毛发状况方面展示较快效果。然而,观测到由原发性健康状况引起的脱发视疾病性质而定耗时较长。在患有继发性健康问题的大多数人中,脱发在2至4周内显著减少。然而,患有原发性健康问题的人则耗时约6至12周方可注意到对脱发的预防及毛发纹理的改变,时间范围高度取决于与原发性健康问题相关联的疾病类型。
任何疾病均可影响且确实影响身体剩余部分的健康及其适当从内部滋养皮肤及毛发的能力。具体化调配物从外部维持对皮肤及毛发的滋养。本发明的具体化调配物有助于填补可能因头皮及毛发的疾病或营养不良引起的营养缺口。由此使毛囊足够强壮以继续维持健康结构。
包括具体化调配物所涵盖各成分的详细资讯的清单包括:
玫瑰水。已知玫瑰水具有消炎特性且缓和受刺激的皮肤,其亦有助于增强皮肤细胞且使皮肤组织再生的重要抗氧化剂来源。另外,已知玫瑰水刺激皮肤下微小血管的循环。此外,玫瑰水有助于维持皮肤pH平衡、镇定皮炎及湿疹。已知玫瑰水使皮肤水合且恢复活力,同时治愈可由各种天然因素(诸如意外)以及由对头皮的化学损伤引起之瘢痕、切口及伤口。另外,玫瑰水有助于使毛干水合并进行修护,且有助于使毛干变强壮且具有柔韧性以有助于抵抗毛发断裂。
蓖麻油。蓖麻油包含重要组分,包括营养素、蛋白质、矿物质及维生素E,其全部为健康毛发所需。蓖麻油亦富有抗细菌及抗真菌特性且具有多种脂肪酸,包括蓖麻油酸。蓖麻油酸有助于保护毛发且刺激营养丰富的血液循环至头皮。此外,在蓖麻油中发现的全部范围的胺基酸及ω-6脂肪酸有助于防止末端分叉及毛发断裂。蓖麻油能够深度渗透至头皮中且使粗糙毛发及角质层平滑。
瑞香草油。瑞香草油有益于头皮健康及毛发再生长,此油经强烈浓缩且含有瑞香草酚,已知其具有防腐特性。瑞香草油提供清洁及再生毛囊之益处。瑞香草油另外含有已知可改良毛发健康之原维生素A、维生素C及角蛋白(Keratin)。
迷迭香油。迷迭香油是最早的毛发生长强化精油之一,其刺激健康毛发生长。它成功用于圆秃(脱发)治疗中。迷迭香油减缓过早脱发及白发。迷迭香油亦有益于治疗头皮屑。迷迭香具有强化头皮之能力且对致力于消除湿疹、皮炎及油性头皮有益。
德国洋甘菊油。已知德国洋甘菊油有助于舒缓湿疹、皮疹、伤口、皮炎、皮肤干痒。已知此油具有消炎及抗感染特性,且亦有助于舒缓对化学品的过敏反应。此油有助于使皮肤组织再生且可借助拉直其发根使毛发恢复活力。
椰子油。椰子油包含天然抗氧化剂及营养素,其在涂覆至毛发时有助于改良其柔软度及光泽感。此油富含维生素E、维生素K及铁且在增强毛发生长同时有效地消除头皮屑。椰子油有效地改良头皮循环且增强营养素与氧传递至毛发。在椰子油内发现的脂肪酸与毛发中的蛋白结合且保护毛发的发根及毛干以免断裂。特定而言,在椰子油中发现的月桂酸改良毛发健康。椰子油在添加至具体化的毛发康复与保护实施态样中时发挥二种主要功能。首先,椰子油的疏水特性使其可抑制来自周围空气及环境的水的渗透。其次,椰子油能够与毛发的天然蛋白质结构结合,此有助于毛发保持其天然水分含量且强化毛发纤维,因此使其更为强健。
甜杏仁油。甜杏仁油是维生素A、B及E之丰富来源。此油有助于移除死亡皮肤细胞及杂质以及减少皮肤发炎、发红及发痒。甜杏仁油是一种良好的软化剂且具有使其极度适用于治疗诸如牛皮癣及湿疹的皮肤问题的特性。甜杏仁油刺激毛发生长,强化毛发,减少毛发断裂且增加光泽、平滑发梢且减少卷曲。
熏衣草油。熏衣草不仅有益于大脑,而且亦有益于健康头皮及毛发生长。由于熏衣草油是一种天然消炎剂,因此其有助于维持健康头皮且可用于治疗头皮屑及头皮的牛皮癣。借助保持该等陷入困境的头皮状况且增强头皮的血液循环,使头皮复原且展示健康改良的迹象。另外,熏衣草油增强血液循环以进一步改良头皮的健康。
橄榄油。橄榄油更令人惊讶的益处之一在于,其可预防且甚至可治愈脱发。人们脱发是由于造成毛囊干收缩的激素所致。然而,在向头皮涂覆橄榄油时,此种激素(称为二氢睾固酮,DHT)的产生即受到阻碍。头皮的总体健康亦受益于橄榄油,而健康头皮等同于健康毛发。另外,橄榄油的天然润发乳特性为头皮增加水分,头皮是人们倾向于忽略的区域。除治愈干燥头皮以外;橄榄油使毛发变得柔软且有光泽,而且具有击退常见头皮与毛发问题的抗细菌与抗真菌特性。此外,向头皮涂覆橄榄油可预防或阻止头皮屑或甚至头虱。
葡萄籽油。葡萄籽油有助于毛发更快生长,且此精油含有几乎所有对于毛发健康生长而言重要的营养素。它具有维生素E、亚麻油酸、蛋白及矿物质,该等物质在将油局部涂覆之后几乎即刻滋养毛发及头皮。一般而言,在对毛发提供维生素E与其他重要营养素的滋养来源时,毛发生长更快且更强健。另外,葡萄籽油具有若干重要的健康益处,在于其是必需脂肪酸与维生素E的良好来源,而且在此油中发现的多酚及类黄酮含有强抗氧化剂化合物。此外,在葡萄籽油中发现的类黄酮“寡聚前花青素(oligomericprocyanidin)”是一种极强的抗氧化剂,比诸如维生素C与E等抗氧化剂强约50倍,使得含有此类黄酮的葡萄籽油成为极强的自由基捕获剂且提供保护以免由自由基引起的细胞及组织损伤。另外,葡萄籽油可有助于强化及修复受损或破坏的毛细管及血管。
胡萝卜油。胡萝卜油是一种有效的毛发及皮肤护理乳液,因为其富含胡萝卜素、抗氧化剂及胺基酸。胡萝卜油对皮肤更新以及毛发生长有利。其亦使皮肤恢复活力并调理肤色,在皮炎、湿疹及皮疹的情形下有所助益。由于胡萝卜籽油含有胡萝卜素及维生素A,因此其对健康皮肤及毛发亦极为有利。
山金车油。山金车油借助使结合废物的流体排出并使清洁流体及血小板进入受感染区域而有助于加速毛发及组织的愈合过程。山金车油被认为是预防脱发的最佳香精油之一,且其是可信的用于神经性脱发的草药治疗。基于山金车油的制剂在顺势疗法中亦熟知作为对各种毛发相关问题的治疗,诸如扩散性秃头、白发及头皮屑。另外,山金车油是一种具有抗氧化剂特性的强消炎剂,其充实头皮且保护毛发免受因粗糙元素及环境污染引起的损害。
茶树油。茶树油有助于移除死亡皮肤细胞且是一种强效的头皮净化剂。此油可用于治疗头皮病况,诸如牛皮癣及头皮屑,且借助改良整个头皮上的血液循环来促进毛发生长。茶树油促进出汗,这又导致皮肤解毒作为污染物,且大量感染剂被排出体外。
伪胶原蛋白。伪胶原蛋白(源自酵母的胶原蛋白等效物):此源自酵母的真皮基质物质是由活细胞获得的真实保湿醣蛋白。其借助受控方法自酵母萃取,该方法维持其高分子量及天然结构,使其完美加入皮肤与毛发产品中。伪胶原蛋白可用于多种毛发护理配方中,提供质感与光泽,且使烫过的毛发看起来更柔软而较不毛糙。
案树油。案树油增加毛发的弹性,使其更强健且更可抵抗毛发断裂及发梢分叉。此油具有防腐及抗真菌特性,且可借助防止微生物生长来保持头皮健康,此又可促进毛发健康生长。此油对除去头皮屑有效,头皮屑系可引起脱发的常见头皮问题。头皮屑亦可抑制毛发生长。案树油对其他头皮问题可提供缓解,诸如轻度形式的牛皮癣、头皮丘疹及头皮干燥。另外,此油可润湿及缓和干燥皮肤且改良血液流向头皮,此可有助于消除油及细菌在毛囊中聚集。由于适当的血液循环确保向毛囊供应充足的营养素,其借助改良头皮循环来刺激毛发生长,因此此油可使无光泽毛发恢复活力且改良毛发质地。案树油亦增加神经酰胺的产量,神经酰胺在发束中天然存在的一种脂质分子类型。神经酰胺有助于保持毛鳞片完整,且防止发束的天然水分及蛋白损失。此又使毛发的强度、光泽及弹性增加。
雪松木油。雪松木精油具有强效的防腐性、抗脂溢性、收敛性及杀真菌特性,这使其成为对于头皮真菌感染及刺激性头皮屑病况而言有效的治疗及预防剂。此油的收敛特性有助于深度清洁头皮及毛干以使得发根及毛囊可呼吸,而抗脂溢性特性借助阻止产生多余皮脂来校正皮脂腺失衡的功能。
鳄梨油。鳄梨油充满促使且维持毛发锁住丝滑感的健康毛发维生素。此油亦含有有助于结合分叉发梢、滋养毛囊且促进毛发较快生长的胺基酸。鳄梨油中的各种营养素保护毛发免受环境污染。另外,此油可强化发束、增加少许光泽且使毛发超级柔顺。
荷荷芭油。荷荷芭油具有抗细菌及杀真菌特性,其可用于保持头皮健康。此油有助于减少由诸如头皮皮炎、牛皮癣及湿疹等因素引起之脱发。荷荷芭油是一种优良的润发乳(hairconditioner),其可用于摆脱干燥、卷曲及难以打理的毛发。另外,此油有助于密封毛干中之水分且借助使因粗糙化学品及污染物引起的损伤降至最低程度而为毛发增添天然光辉及光泽。
牛油树油脂。牛油树油脂的主要组分包括油酸、硬脂酸、亚麻油酸及其他。油脂在体温下融化时即快速吸收至皮肤中。牛油树油脂因其治愈特性而著名,此可归因于存在若干种脂肪酸及植物固醇,诸如油酸、棕榈酸、硬脂酸及次亚麻油酸。该等油溶性组分在与碱接触时不经历皂化或转化为肥皂。另外,牛油树油脂比其他坚果油及脂肪更不可皂化,因此赋予其对皮肤的更大治愈潜能。油脂含有植物抗氧化剂(诸如维生素A及E)以及儿茶素。维生素A及E保护细胞免受自由基及环境损害。此外,牛油树油脂具有牛油树脂中的肉桂酸酯,其有助于防止皮肤免受紫外线辐射损害。在牛油树油脂中发现若干种展示出消炎特性的肉桂酸衍生物。由于富含宝贵成分,诸如具有大比例不可皂化组分的不饱和脂肪、必需脂肪酸、维生素E及D、植物固醇、原维生素A及尿囊素,因此牛油树油脂被认为是皮肤之超级食物。
芦荟油。芦荟油为预防脱发以及移除头皮屑及治疗皮脂溢出提供巨大益处。当出现头皮屑时,通常伴随脱发问题。实际上,为适当地治疗脱发,首先需要处理头皮屑问题。毛发与头皮之天然pH水准在4与4.5之间,而芦荟的pH水准为4.5至5.5。因此,植物在不使用其他化学物质的情形下即可用于使毛发及头皮恢复其天然状况。毛发与头皮之适当pH水准有助于毛发维持其保持水分的能力。
鼠尾草油。鼠尾草油属于最佳的头皮净化剂。咸信用作清洗液的鼠尾草精油的强烈浸渍使白发变黑且属于最可信的草药脱发解决方案。另外,鼠尾草油具备抗氧化、防腐及抗真菌特性。
聚甘油油酸酯。聚甘油油酸酯系基于植物油酸之蒸馏三甘油酯,其不含PEG。其是黄色至琥珀色液体且具有温和气味。聚甘油油酸酯分散于水中且亲水性-亲脂性平衡(hydrophilic-lipophilicbalance;HLB)为5(产生油包水乳液)。INCI名称为聚甘油-4油酸酯。聚甘油油酸酯的一般化学特性使其成为优良的乳化剂(其可自由使得水与油混合)。
PEG-7甘油椰油酸酯。描述:由甘油与椰子油制得的非离子性、乙氧基化聚乙二醇酯。其为透明的油性液体,具有特征性气味。该化合物可溶于水及醇中,但不溶于油中。HLB值为11(产生水包油乳液)。CAS#为68201-46-7且INCI名称为:聚氧乙烯(PEG-7)甘油单椰油酸酯。该化合物的特性在于其为具有优良乳化、软化、再脂化及增稠特性的多功能剂,且适合作为表面活性剂及泡沫增强剂,且对于柔软及光滑皮肤具有良好的调理作用。
安那根是具有已知有助于毛发生长及/或补救脱发之特性的豌豆(PisumSativum,Pea)苗芽萃取物。
贝夕波是一种亦已知有助于毛发生长及/或补救脱发的含水(水)变性酒精(AlcoholDenat)、泛醇甘油(PanthenolGlycerin)、常见肥皂草萃取物H.G(CommonSoapwortExtractH.G)、羟乙基鲸蜡基二甲基磷酸铵(HydroxyethylCetyldimoniumPhosphate)、贝夕波TM(baicapilTM)、水、乳酸混合物。
萨克胶耶欧夫拜欧是包含甘油与甜扁桃(PrunusAmygdalusDulcis)(甜杏仁)油与蔗糖月桂酸酯与甜橙(CitrusAurantiumDulcis)(Orange)果汁水的调配物成分组合。
借助在单一调配物中调配上文所列以上成分的组合,最终结果是一种具有能够快速且有效地阻止及预防脱发的能力的超强调配物。选定成分组合一起作用以拉直、澄清、中和及治愈头皮。具体化调配物是一种用于毛发及头皮的药物。其治愈毛发的发根至发梢。具体化调配物能够深度渗透至皮肤层中,且具有清除毛囊杂质且使毛囊畅通的能力。借助使毛囊畅通,调配物使得毛发可在无任何限制的情形下生长及膨胀。由此创造理想环境以供健康毛发再生长。具体化调配物亦能够在短时间内重建受损组织,使得对于头皮因化学品受损者而言理想地用以再生出产生健康毛发的能力。另外,具体化调配物有助于存在皮肤问题者舒缓皮炎、湿疹及其他皮肤相关问题。每种成分就其自身而言是独特的,然而在以适当比率组合在一起时,各组分协同作用使得调配物在首次使用后即具有显著作用。
现将参考以下非限制性实施例来论述本发明的详情。
实施例1
成分 | 盎司 | 总% | 范围 |
玫瑰水 | 54 | 28.8% | 25-30% |
案树油 | 14 | 7.5% | 5-10% |
蓖麻油 | 12 | 6.4% | 5-8% |
瑞香草油 | 12 | 6.4% | 5-8% |
迷迭香油 | 10 | 5.3% | 4-6% |
德国洋甘菊油 | 8 | 4.3% | 3-5% |
胡萝卜油 | 8 | 4.3% | 3-5% |
椰子油 | 6 | 3.2% | 2-4% |
甜杏仁油 | 6 | 3.2% | 2-4% |
雪松木油 | 4 | 2.1% | 1-3% |
橄榄油 | 4 | 2.1% | 1-3% |
葡萄籽油 | 4 | 2.1% | 1-3% |
熏衣草油 | 4 | 2.1% | 0.5-2.5% |
山金车油 | 3 | 1.6% | 0.5-2.5% |
荷荷芭油 | 3 | 1.6% | 0.5-2.0% |
芦荟油 | 2 | 1.1% | 0.5-2.0% |
茶树油 | 2 | 1.1% | 0.5-2.0% |
伪胶原蛋白 | 2 | 1.1% | 0.5-2.0% |
植物甘油 | 2 | 1.1% | 0.5-2.0% |
牛油树油脂 | 2 | 1.1% | 0.5-2.0% |
鼠尾草油 | 0.5 | 0.3% | 0.1-0.6% |
聚甘油油酸酯 | 20 | 10.7% | 8-12% |
PEG-7-甘油椰油酸酯 | 5 | 2.7% | 2-4% |
总盎司数 | 187.5 |
实施例调配物1
调配产物的方法。调配方法是利用二个容器,第一容器具有油及其他成分且第二容器具有玫瑰水及乳化剂。所示实例性调配物批次包括约187.5盎司的最终批量。
步骤1
在第一容器中,将以下成分按以下量混合于一起:14盎司的案树油、12盎司的蓖麻油、12盎司的瑞香草油、10盎司的迷迭香油、8盎司的德国洋甘菊油、8盎司的胡萝卜油、6盎司的椰子油(添加之前在锅中熔融)、6盎司的甜杏仁油、4盎司的雪松木油、4盎司的橄榄油、4盎司的葡萄籽油、4盎司的熏衣草油、3盎司的山金车油、3盎司的荷荷芭油、2盎司的芦荟油、2盎司的茶树油、2盎司的伪胶原蛋白、2盎司的植物甘油、2盎司的牛油树油脂(添加之前在锅中熔融)、0.5盎司的鼠尾草油。
步骤2
在第二容器中,将以下成分按以下量混合于一起:54盎司的玫瑰水、20盎司的聚甘油油酸酯、及5盎司的PEG-7-甘油椰油酸酯。
步骤3
在完成步骤1及步骤2之后,将来自第一容器的成分缓慢搅拌至第二容器成分中并混合。将该等成分混合于一起之后,调配物包含待用的乳油状浆液。
实施例2
实施例调配物2
步骤1
量测并混合蓖麻油、甜杏仁油、橄榄油、葡萄籽油、牛油树油脂、椰子油、荷荷巴油、植物甘油及伪胶原蛋白。
步骤2
量测并混合案树油、瑞香草油、迷迭香油、德国洋甘菊油、胡萝卜籽油、雪松木油、熏衣草油、山金车油、茶树油、鼠尾草油。
步骤3
量测并将贝夕波与安那根一起混合。
步骤4
将萨克胶耶欧夫拜欧均质化3分钟。
第1阶段混合步骤1
步骤5
将步骤1缓慢添加至步骤4中且再均质化3分钟。
第2阶段混合步骤1
步骤6
混合步骤2且缓慢均质化至步骤5中直至完全混合(达到完全合并耗时约4分钟)。
第2阶段混合步骤2
步骤7
将步骤3添加至步骤6中并混合。
第3阶段步骤1
将第1阶段混合物缓慢添加至第2阶段中,混合直至完全合并。
在其他实例性实施态样中,调配物可改变且可添加各种其他成分来改变调配物的一些特性,从而产生凝胶、摩丝、洗发精、润发乳、冲洗液及其类似物。视使用者是否试图预防脱发或试图使毛发生长,可改变该等产品的应用。
尽管已参照较佳实施态样描述了本发明,但熟习此项技术者应了解,在不偏离本发明的范围的条件下可进行各种改变且等效物可取代其要素。另外,在不偏离本发明的基本范围的条件下可进行多种修改以使特定的情形或材料适应本发明的教示内容。因此,预期本发明不限于所揭示作为预期用于进行本发明的最佳模式的特定实施态样,而是本发明将包括在随附权利要求书的范围内的所有实施态样。
Claims (11)
1.一种用于治疗脱发的调配物,其特征在于,包含:玫瑰水、案树油、蓖麻油、瑞香草油、迷迭香油、德国洋甘菊油、胡萝卜油、雪松木油(Cederwoodoil)、葡萄籽油、山金车油及伪胶原蛋白(Pseudocollagen)。
2.如权利要求1所述的调配物,其特征在于,更包含至少一种选自以下的油:椰子油、甜杏仁油、橄榄油、熏衣草油、荷荷芭油及茶树油。
3.如权利要求1所述的调配物,其特征在于,更包含:椰子油、甜杏仁油、橄榄油、熏衣草油、荷荷芭油或茶树油。
4.如权利要求1所述的调配物,其特征在于,更包含至少一种选自以下的成分:植物甘油、牛油树油脂、鼠尾草油、聚甘油油酸酯(PolyglycerylOleate)、PEG-7-甘油椰油酸酯(PEG-7-GlycerylCocoate)、安那根(Anagain)、贝夕波(Baicipil)及萨克胶耶欧夫拜欧(SucragelAOFBio)。
5.如权利要求2所述的调配物,其特征在于,更包含至少一种选自以下的成分:植物甘油、牛油树油脂、鼠尾草油、安那根、贝夕波及萨克胶耶欧夫拜欧。
6.如权利要求1所述的调配物,其特征在于,更包含:植物甘油、牛油树油脂、鼠尾草油、安那根、贝夕波及萨克胶耶欧夫拜欧。
7.如权利要求3所述的调配物,其特征在于,更包含:植物甘油、牛油树油脂、鼠尾草油、安那根、贝夕波及萨克胶耶欧夫拜欧。
8.如权利要求7所述的调配物,其特征在于,其中每种成分的总体积百分比范围为:
55%至65%的玫瑰水、
2%至4%的案树油、
2%至4%的蓖麻油、
2%至4%的瑞香草油、
1%至4%的迷迭香油、
0.001%至1%的德国洋甘菊油、
1%至3%的胡萝卜油、
1%至3%的椰子油、
1%至3%的甜杏仁油、
0.5%至3%的雪松木油、
0.01%至2%的橄榄油、
0.01%至2%的葡萄籽油、
0.01%至2%的熏衣草油、
0.01%至2.5%的山金车油、
0.01%至2.5%的荷荷芭油、
0.01%至2.0%的茶树油、
0.01%至2.0%的伪胶原蛋白、
0.01%至2.0%的植物甘油、
0.5%至2.0%的牛油树油脂、
0.01%至1.0%的鼠尾草油、
2%至6%的安那根、
2%至6%的贝夕波、及
5%至10%的萨克胶耶欧夫拜欧。
9.如权利要求8所述的调配物,其特征在于,其中每种成分的总体积百分比为:
59.5%的玫瑰水、
2.8%的案树油、
2.4%的蓖麻油、
2.4%的瑞香草油、
2.0%的迷迭香油、
0.1%的德国洋甘菊油、
1.6%的胡萝卜油、
1.2%的椰子油、
1.2%的甜杏仁油、
1.2%的雪松木油、
0.8%的橄榄油、
0.8%的葡萄籽油、
0.8%的熏衣草油、
0.6%的山金车油、
0.6%的荷荷芭油、
0.4%的茶树油、
0.4%的伪胶原蛋白、
0.4%的植物甘油、
1.2%的牛油树油脂、
0.1%的鼠尾草油、
4%的安那根、
4%的贝夕波、及
7.5%的萨克胶耶欧夫拜欧。
10.一种促进毛发健康的方法,其特征在于,包含投与有效量的如权利要求1所述的调配物。
11.一种促进毛发健康的方法,其特征在于,包含投与有效量的如权利要求9所述的调配物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210852549.8A CN115040592A (zh) | 2014-06-30 | 2015-06-30 | 脱发预防及修复调配物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/320,176 US9427394B2 (en) | 2014-06-30 | 2014-06-30 | Hair loss prevention and restoration solution |
US14/320176 | 2014-06-30 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210852549.8A Division CN115040592A (zh) | 2014-06-30 | 2015-06-30 | 脱发预防及修复调配物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105213639A true CN105213639A (zh) | 2016-01-06 |
Family
ID=54929334
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210852549.8A Pending CN115040592A (zh) | 2014-06-30 | 2015-06-30 | 脱发预防及修复调配物 |
CN201510386004.2A Pending CN105213639A (zh) | 2014-06-30 | 2015-06-30 | 脱发预防及修复调配物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210852549.8A Pending CN115040592A (zh) | 2014-06-30 | 2015-06-30 | 脱发预防及修复调配物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9427394B2 (zh) |
CN (2) | CN115040592A (zh) |
HK (1) | HK1219429A1 (zh) |
TW (1) | TWI754607B (zh) |
WO (1) | WO2016003493A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017185245A1 (zh) * | 2016-04-27 | 2017-11-02 | 深圳汉草药研纳米生物科技有限公司 | 一种治疗脱发和促进生发的中药精油组合物及其制备方法 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101645640B1 (ko) * | 2016-01-26 | 2016-08-05 | 이재도 | 탈모방지, 발모촉진, 또는 양모촉진용 조성물, 및 그 제조방법 |
JP6664004B2 (ja) * | 2016-01-27 | 2020-03-13 | イーエルシー マネージメント エルエルシー | 薄毛の外観を処置する方法 |
WO2017131957A1 (en) * | 2016-01-27 | 2017-08-03 | Elc Management Llc | A method for treating the appearance of thinning hair |
US10029843B2 (en) | 2016-03-07 | 2018-07-24 | Elc Management Llc | False eyelash dispenser |
ES2621021B1 (es) * | 2016-06-07 | 2017-10-13 | Khadija EL HATTAB BINTAOUI | Composición para frenar y prevenir la caída del pelo y el procedimiento de obtención |
US10632062B2 (en) * | 2018-04-11 | 2020-04-28 | Joyce Turner | Hair care composition |
FR3145872A1 (fr) * | 2022-08-22 | 2024-08-23 | Ahmed Kadri | Composition favorisant la croissance des kératinocytes et l'angiogenèse et ses applications thérapeutiques et cosmétiques. |
CN116712526A (zh) * | 2023-07-04 | 2023-09-08 | 云曼(深圳)健康科技有限公司 | 一种防脱生发精华液及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103079540A (zh) * | 2010-07-01 | 2013-05-01 | 高道尹 | 制备具有增强功效的包含芳香油混合物的头发和头皮护理组合物的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005010142A1 (de) * | 2005-03-02 | 2005-11-03 | Dr. Kurt Wolff Gmbh & Co. Kg | Mittel zur Aktivierung der Haarwurzeln und Verwendung des Mittels |
CN100544724C (zh) * | 2006-01-05 | 2009-09-30 | 许多全 | 乌洛托品用于制备治疗预防头屑多头皮痒脱发的药剂中的应用 |
WO2009099167A1 (ja) * | 2008-02-06 | 2009-08-13 | Showa Denko K.K. | 養毛化粧料 |
-
2014
- 2014-06-30 US US14/320,176 patent/US9427394B2/en active Active
-
2015
- 2015-01-23 WO PCT/US2015/012742 patent/WO2016003493A1/en active Application Filing
- 2015-06-30 TW TW104121113A patent/TWI754607B/zh active
- 2015-06-30 CN CN202210852549.8A patent/CN115040592A/zh active Pending
- 2015-06-30 CN CN201510386004.2A patent/CN105213639A/zh active Pending
-
2016
- 2016-06-28 HK HK16107528.8A patent/HK1219429A1/zh unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103079540A (zh) * | 2010-07-01 | 2013-05-01 | 高道尹 | 制备具有增强功效的包含芳香油混合物的头发和头皮护理组合物的方法 |
Non-Patent Citations (3)
Title |
---|
刘艳等: "《看发-从"头发"看健康》", 31 October 2007, 科学技术文献出版社 * |
施杞等: "《家庭实用中医全书》", 30 June 1992, 知识出版社发行 * |
无: "龙沙lonza", 《WWW.BAIWANX.CN/USERLIST/HKMY/NEWSHOW-45299.HTML》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017185245A1 (zh) * | 2016-04-27 | 2017-11-02 | 深圳汉草药研纳米生物科技有限公司 | 一种治疗脱发和促进生发的中药精油组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115040592A (zh) | 2022-09-13 |
US9427394B2 (en) | 2016-08-30 |
WO2016003493A1 (en) | 2016-01-07 |
TWI754607B (zh) | 2022-02-11 |
TW201601773A (zh) | 2016-01-16 |
US20150374613A1 (en) | 2015-12-31 |
HK1219429A1 (zh) | 2017-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105213639A (zh) | 脱发预防及修复调配物 | |
CN104042528B (zh) | 草本养发防脱去屑洗发原液及制作方法 | |
KR101509608B1 (ko) | 두피 및 모발 상태 개선용 조성물 | |
KR100960054B1 (ko) | 탈모방지 및 두피개선을 위한 두발 화장품 조성물 | |
US20120204894A1 (en) | Hair growth conditioner | |
US9427395B2 (en) | Composition for promoting hair growth | |
US9956162B2 (en) | Hair care compositions for promoting hair growth and preventing hair loss | |
KR101196523B1 (ko) | 천연물 발효 추출물을 유효성분으로 하는 발모제 조성물 | |
KR100782273B1 (ko) | 탈모 예방 및 양모 촉진용 조성물 | |
KR101206998B1 (ko) | 탈모방지 및 발모용 두피 케어 조성물 및 이를 이용한 헤어 제품 | |
KR20180137101A (ko) | 마사지용 화장료 조성물 | |
CN107281048A (zh) | 一种无硅油中药调理洗发水及其制备方法 | |
US9066952B1 (en) | Rejuvenating hair oil system and method of use | |
CN107519046A (zh) | 一种防脱固发生发组合物、制备方法及其应用 | |
KR100780577B1 (ko) | 탈모 예방 및 양모 촉진용 천연 복합 조성물 | |
US20070154432A1 (en) | Compositions and methods for hair growth | |
US10111827B2 (en) | Hair loss prevention and restoration solution | |
KR102373929B1 (ko) | 천연물 복합 추출물을 함유하는 천연 샴푸 및 에센스 제형의 두피케어용 화장품 조성물 | |
JPH09194334A (ja) | 養毛・育毛剤 | |
US20190216871A1 (en) | Diabetic foot cream | |
CN108815088A (zh) | 一种防脱生发洗发液及其制备方法 | |
KR20170092281A (ko) | 캐모마일을 이용한 기능성 화장료 조성물 | |
KR20110002955A (ko) | 생약추출액이 함유된 샴푸조성물 | |
US20230302076A1 (en) | Natural and Organic Composition for Preventing Hair Loss and Promoting Hair Growth | |
KR20130072895A (ko) | 백합 추출액을 이용한 탈모방지 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1219429 Country of ref document: HK |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160106 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1219429 Country of ref document: HK |